Tango Therapeutics, Inc. (TNGX)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $3.81B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,231,121
- 52-week high
- —
- 52-week low
- —
- Open
- $28.50
- Day high
- $29.34
- Day low
- $27.51
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $62.38M | -$101.59M | -$0.87 |
| 2024 | $42.07M | -$130.3M | -$1.19 |
| 2023 | $36.53M | -$101.74M | -$1.08 |
| 2022 | $24.86M | -$108.18M | -$1.23 |
| 2021 | $37.04M | -$58.24M | -$0.94 |
About Tango Therapeutics, Inc.
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
- CEO
- Malte Peters
- Employees
- 155
- Country
- US
- IPO date
- Sep 3, 2020
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Tango Therapeutics, Inc.'s stock price today?
- TNGX is trading at $27.54 as of Jul 20, 2026.
- What is Tango Therapeutics, Inc.'s market cap?
- Tango Therapeutics, Inc. (TNGX) has a market capitalization of $3.81B.
- Does Tango Therapeutics, Inc. pay a dividend?
- Tango Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Tango Therapeutics, Inc. in?
- Tango Therapeutics, Inc. operates in the Healthcare sector.